Filing Details
- Accession Number:
- 0001144204-15-063094
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-11-05 16:30:28
- Reporting Period:
- 2015-11-03
- Filing Date:
- 2015-11-05
- Accepted Time:
- 2015-11-05 16:30:28
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1369868 | China Biologic Products Inc. | CBPO | Biological Products, (No Disgnostic Substances) (2836) | 752308816 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1331795 | David Gao | 18Th Floor, Jialong International Building, 19 Chaoyang Park Road Beijing F4 100125 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-11-03 | 88,531 | $115.63 | 384,460 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-11-04 | 7,460 | $115.19 | 377,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Represents 95,991 shares of common stock sold through a 10b5-1 trading plan (the "10b5-1 Plan") previously disclosed on the Reporting Person's Form 4 filed with the Securities and Exchange Commission (the "Commission") on October 21, 2015. To date, all the shares that may be sold pursuant to the 10b5-1 Plan have been sold in open market transactions.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in the open market at prices ranging from $115.00 to $116.65, inclusive.*
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in the open market at prices ranging from $115.00 to $115.75, inclusive.*